Tran Dat T, Ohinmaa Arto, Thanh Nguyen X, Howlett Jonathan G, Ezekowitz Justin A, McAlister Finlay A, Kaul Padma
School of Public Health (Tran, Ohinmaa, Thanh), University of Alberta; Institute of Health Economics (Ohinmaa, Thanh), Edmonton; Department of Medicine (Howlett), University of Calgary, Calgary; Department of Medicine (Ezekowitz, McAlister, Kaul), University of Alberta; Canadian VIGOUR Centre (Ezekowitz, McAlister, Kaul), University of Alberta, Edmonton, Alta.
CMAJ Open. 2016 Jul 21;4(3):E365-E370. doi: 10.9778/cmajo.20150130. eCollection 2016 Jul-Sep.
Heart failure is a costly health condition and a major public health concern. We sought to examine the costs of hospital admissions for heart failure between fiscal years 2004 and 2013 in Canada and to model the future costs to 2030.
Canadian Institutes for Health Information Discharge Abstract Database was used to identify admissions to hospital with heart failure as the primary diagnosis between fiscal years 2004 and 2013. Multiple linear regression models were used to calculate the trend in prevalence and extrapolate these to 2030. Canadian Institutes for Health Information patient cost estimates were used to identify costs of hospital admissions for heart failure. Generalized linear models were used to estimate average annual costs per heart failure patient. We conducted a sensitivity analysis including all admissions for heart failure in any diagnostic field.
In 2013, 45 600 (95% confidence interval [CI]: 43 800-47 200) patients were admitted with heart failure as the primary diagnosis, accounting for $482 (95% CI $464-$500) million. By 2030, we estimate 54 000 (95% CI 49 000-60 000) patients and costs of $722 (95% CI $650-$801) million, with older adults (age ≥ 80 yr) accounting for 52% of costs. Including admissions for which heart failure was a secondary diagnosis increases the total cost to $2.8 (95% CI $2.6-$3.0) billion in 2030.
As in other developed countries, hospital costs related to heart failure in Canada are on the rise. Older adults are the main consumers of such hospital services. Strategies to improve outpatient care to reduce rates of admission for heart failure are needed.
心力衰竭是一种成本高昂的健康状况,也是一个主要的公共卫生问题。我们试图研究2004财年至2013财年加拿大心力衰竭住院治疗的费用,并对到2030年的未来费用进行建模。
使用加拿大卫生信息研究所出院摘要数据库来识别2004财年至2013财年期间以心力衰竭为主要诊断的住院病例。采用多元线性回归模型计算患病率趋势,并外推至2030年。利用加拿大卫生信息研究所的患者费用估计来确定心力衰竭住院治疗的费用。使用广义线性模型估计每位心力衰竭患者的年均费用。我们进行了敏感性分析,包括任何诊断领域中所有心力衰竭住院病例。
2013年,有45600例(95%置信区间[CI]:43800 - 47200)患者以心力衰竭为主要诊断入院,费用为4.82亿加元(95%CI 4.64亿 - 5.00亿加元)。到2030年,我们估计有54000例(95%CI 49000 - 60000)患者,费用为7.22亿加元(95%CI 6.50亿 - 8.01亿加元),其中老年人(年龄≥80岁)占费用的52%。将心力衰竭作为次要诊断的住院病例包括在内,到2030年总费用增加到28亿加元(95%CI 26亿 - 30亿加元)。
与其他发达国家一样,加拿大与心力衰竭相关的医院费用正在上升。老年人是此类医院服务的主要消费者。需要采取策略改善门诊护理,以降低心力衰竭的入院率。